S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NYSE:RE

Everest Re Group Stock Forecast, Price & News

$268.40
-9.50 (-3.42%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$264.33
$271.37
50-Day Range
$250.41
$286.62
52-Week Range
$209.63
$289.68
Volume
139,796 shs
Average Volume
270,306 shs
Market Capitalization
$10.65 billion
P/E Ratio
10.66
Dividend Yield
2.23%
Beta
0.68
30 days | 90 days | 365 days | Advanced Chart
Receive RE News and Ratings via Email

Sign-up to receive the latest news and ratings for Everest Re Group and its competitors with MarketBeat's FREE daily newsletter.


Everest Re Group logo

About Everest Re Group

Everest Re Group Ltd. is a holding company, which engages in the provision of reinsurance and insurance services. It operates through the following segments: U.S. Reinsurance, International, Bermuda, and Insurance. The U.S. Reinsurance segment writes property and casualty reinsurance and specialty lines of business, including marine, aviation, surety, and accident and health business, on both a treaty and facultative basis, through reinsurance brokers, as well as directly with ceding companies primarily within the U.S. The International segment offers foreign property and casualty reinsurance through Everest Re's branches in Canada and Singapore and through offices in Brazil, Miami, and New Jersey. The Bermuda segment comprises reinsurance and insurance to worldwide property and casualty markets through brokers and directly with ceding companies from its Bermuda office and reinsurance to the United Kingdom and European markets through its UK branch and Ireland Re. The Insurance segment writes property and casualty insurance directly and through brokers, surplus lines brokers, and general agents within the U.S., Canada, and Europe. The company was founded in 1999 and is headquartere

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Fire, marine, & casualty insurance
Sub-Industry
Reinsurance
Sector
Finance
CUSIP
G3223R10
Employees
1,746
Year Founded
1973

Sales & Book Value

Annual Sales
$9.60 billion
Cash Flow
$8.61 per share
Book Value
$251.45 per share

Profitability

Net Income
$514.15 million
Pretax Margin
10.12%

Debt

Price-To-Earnings

Miscellaneous

Free Float
39,169,000
Market Cap
$10.65 billion
Optionable
Optionable

Company Calendar

Ex-Dividend
8/24/2021
Dividend Payable
9/15/2021
Last Earnings
10/27/2021
Today
11/28/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/14/2022

Social Links


MarketRank

Overall MarketRank

2.51 out of 5 stars

Finance Sector

270th out of 1,340 stocks

Fire, Marine, & Casualty Insurance Industry

28th out of 77 stocks

Analyst Opinion: 2.4Community Rank: 3.5Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -












Everest Re Group (NYSE:RE) Frequently Asked Questions

Is Everest Re Group a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Everest Re Group in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Everest Re Group stock.
View analyst ratings for Everest Re Group
or view top-rated stocks.

How has Everest Re Group's stock been impacted by Coronavirus?

Everest Re Group's stock was trading at $227.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, RE stock has increased by 17.7% and is now trading at $268.40.
View which stocks have been most impacted by COVID-19
.

When is Everest Re Group's next earnings date?

Everest Re Group is scheduled to release its next quarterly earnings announcement on Monday, February 14th 2022.
View our earnings forecast for Everest Re Group
.

How were Everest Re Group's earnings last quarter?

Everest Re Group, Ltd. (NYSE:RE) announced its quarterly earnings results on Wednesday, October, 27th. The insurance provider reported ($1.34) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($1.29) by $0.05. The insurance provider had revenue of $3.03 billion for the quarter, compared to analyst estimates of $2.93 billion. Everest Re Group had a net margin of 8.79% and a trailing twelve-month return on equity of 7.54%. The company's quarterly revenue was up 23.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.42 earnings per share.
View Everest Re Group's earnings history
.

How often does Everest Re Group pay dividends? What is the dividend yield for Everest Re Group?

Everest Re Group announced a quarterly dividend on Thursday, November 18th. Shareholders of record on Wednesday, December 1st will be paid a dividend of $1.55 per share on Wednesday, December 22nd. This represents a $6.20 dividend on an annualized basis and a yield of 2.31%. The ex-dividend date of this dividend is Tuesday, November 30th.
View Everest Re Group's dividend history
.

Is Everest Re Group a good dividend stock?

Everest Re Group pays an annual dividend of $6.20 per share and currently has a dividend yield of 2.23%. The dividend payout ratio of Everest Re Group is 24.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Everest Re Group will have a dividend payout ratio of 19.65% next year. This indicates that Everest Re Group will be able to sustain or increase its dividend.
View Everest Re Group's dividend history.

What price target have analysts set for RE?

6 analysts have issued 1-year price targets for Everest Re Group's shares. Their forecasts range from $275.00 to $335.00. On average, they anticipate Everest Re Group's stock price to reach $308.83 in the next year. This suggests a possible upside of 15.1% from the stock's current price.
View analysts' price targets for Everest Re Group
or view top-rated stocks among Wall Street analysts.

Who are Everest Re Group's key executives?

Everest Re Group's management team includes the following people:
  • Juan C. Andrade, President, Chief Executive Officer & Director
  • Ari Moskowitz, Chief Operations Officer & Senior Vice President
  • Mark Kociancic, Chief Financial Officer & Executive Vice President
  • Sanjoy Mukherjee, Secretary, Chief Compliance Officer & Executive VP
  • Ronald D. Diaz, Executive Vice President & Head-International

What is Juan Andrade's approval rating as Everest Re Group's CEO?

1 employees have rated Everest Re Group CEO Juan Andrade on Glassdoor.com. Juan Andrade has an approval rating of 100% among Everest Re Group's employees. This puts Juan Andrade in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Everest Re Group's key competitors?

What other stocks do shareholders of Everest Re Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Everest Re Group investors own include Johnson & Johnson (JNJ), Home Depot (HD), AbbVie (ABBV), UnitedHealth Group (UNH), Exxon Mobil (XOM), Bank of America (BAC), iShares Nasdaq Biotechnology ETF (IBB), Northrop Grumman (NOC), Phillips 66 (PSX) and Adobe (ADBE).

What is Everest Re Group's stock symbol?

Everest Re Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "RE."

Who are Everest Re Group's major shareholders?

Everest Re Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.86%), Boston Partners (5.80%), Franklin Resources Inc. (4.78%), Victory Capital Management Inc. (3.54%), Massachusetts Financial Services Co. MA (2.66%) and Alliancebernstein L.P. (2.13%). Company insiders that own Everest Re Group stock include Geraldine Losquadro, John P Doucette, Joseph V Taranto and William F Galtney Jr.
View institutional ownership trends for Everest Re Group
.

Which major investors are selling Everest Re Group stock?

RE stock was sold by a variety of institutional investors in the last quarter, including Aviva PLC, Balyasny Asset Management LLC, Janus Henderson Group PLC, Boston Partners, Schonfeld Strategic Advisors LLC, Zweig DiMenna Associates LLC, Millennium Management LLC, and Bank of Nova Scotia.
View insider buying and selling activity for Everest Re Group
or view top insider-selling stocks.

Which major investors are buying Everest Re Group stock?

RE stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Man Group plc, Massachusetts Financial Services Co. MA, Franklin Resources Inc., Nordea Investment Management AB, Voloridge Investment Management LLC, Jupiter Asset Management Ltd., and AXA S.A..
View insider buying and selling activity for Everest Re Group
or or view top insider-buying stocks.

How do I buy shares of Everest Re Group?

Shares of RE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Everest Re Group's stock price today?

One share of RE stock can currently be purchased for approximately $268.40.

How much money does Everest Re Group make?

Everest Re Group has a market capitalization of $10.65 billion and generates $9.60 billion in revenue each year. The insurance provider earns $514.15 million in net income (profit) each year or $25.18 on an earnings per share basis.

How many employees does Everest Re Group have?

Everest Re Group employs 1,746 workers across the globe.

When was Everest Re Group founded?

Everest Re Group was founded in 1973.

What is Everest Re Group's official website?

The official website for Everest Re Group is www.everestre.com.

Where are Everest Re Group's headquarters?

Everest Re Group is headquartered at 141 Front Street, HAMILTON D0, HM 19.

How can I contact Everest Re Group?

Everest Re Group's mailing address is 141 Front Street, HAMILTON D0, HM 19. The insurance provider can be reached via phone at (441) 295-0006, via email at [email protected], or via fax at 441-295-4828.


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.